PAI-1及其在血栓形成中的作用

被引:20
作者
孙琦
张颖冬
机构
[1] 南京医科大学附属脑科医院神经内科
关键词
纤溶酶原激活物; 抑制剂; 血栓形成;
D O I
暂无
中图分类号
R363 [病理生理学];
学科分类号
摘要
纤溶酶原激活物抑制物 1( P A I 1) 是组织型纤溶酶原激活物(t P A) 的快速抑制物。t P A 与 P A I 1间的动态平衡对维持血浆纤维蛋白溶解系统( 简称纤溶系统) 的稳态起决定性作用。 P A I 1 水平已成为血栓形成性疾病的危险因素。文章综述了 P A I 1 理化特性、 P A I 1 基因多态性同血浆中 P A I 1 水平相关性及 P A I 1水平和血栓形成的关系。
引用
收藏
页码:218 / 221
页数:4
相关论文
共 18 条
  • [1] Five frequent polymorphismsof plasminogen activator inhibitor 1 gene :lack of association betweengenotypes , P A Iactivity and triglyceride levels in a healthy population. Henry M,Chomiki N,Scarabin P Y,et al. Arteriosclerosis . 1997
  • [2] Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24
  • [3] Changes in plasma levels of t P A, P A I1 and t P A P A I1 complex in patients with cerebrovascularthrombosis infused with t P A. Takada A,Takada Y,Urano T,et al. Thrombosis Research . 1990
  • [4] Verylowdensity lipoproteinresponse element in the promoter region of the human plasminogen activator inhibitor1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia. Eriksson P,Lennart N,Fredrik K,et al. Arteriosclerosis . 1998
  • [5] The two allele sequences of acom mon polymorphism in the promoter of the plasminogen activator inhibitor1 ( P A I1) gene respond differently to interleukin1 in Hep G2cells. Dawson S,Wiman B,Hamsten A,et al. Journal of Biological Chemistry . 1993
  • [6] Metabolic determinants arem uch more important than genetic polymorphisms in determining the P A I1 activity and antigen plasma concentrations : a family study withpart of the Stanislas cohort. Henry M,Tregouet M C,Alessi M F,et al. Arteriosclerosis . 1998
  • [7] P A I1 synthesis in humanhepatoma cell line Hep G2 is increased by cytokinesevidence that theliver contributes to the acute phase behaviour of P A I. De Boer J,Abbnik J,Van Mourik J,et al. Thrombosis and Haemostasis . 1991
  • [8] P A I1 plasma levelsin a general population without clinical evidence of atherosclerosis :relation to environmental and genetic determinants. Margaglione M,Giuseppe C,Donatella C,et al. Arteriosclerosis . 1998
  • [9] Analysis of risk factors for recurrentcerebral infarction. Zhang Y D,Shi J P,Li Z H,et al. J Neurol . 1998
  • [10] Abnormally high circulation levels of tissue plasminogen activator and plasminogen activatorinhibitor1 in patients with a history ofischemic stroke. Margaglion M,Di Minno G,Grandone E,et al. Arteriosclerosis . 1994